Lunesta Generic Release

The generic equivalent of Lunesta tablets (eszopiclone) has been released, following FDA approval. Lunesta is a widely prescribed sedative used to treat insomnia. During the 180-day exclusivity period, multiple companies have received FDA approval to market eszopiclone in various strengths.

Generic prescription drugs approved by the FDA have the same high quality and strength as brand-name drugs. Generic prescription drug manufacturing and packaging sites must pass the same quality standards as those of brand-name drugs.

Over the next 30 days, Carlisle Medical will be contacting physicians to inform them that the generic version of Lunesta (eszopiclone) is available.

If you have any questions or if we may assist you with your pharmacy needs, please contact us at 800-553-1783 or at pharmacy@carlislemedical.com.